tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Apimeds Pharmaceuticals US Inc

APUS
Add to Watchlist
5.150USD
+0.230+4.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
64.77MMarket Cap
LossP/E TTM

Apimeds Pharmaceuticals US Inc

5.150
+0.230+4.67%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

APUS Financials

See Apimeds Pharmaceuticals US Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Apimeds Pharmaceuticals US Inc Earnings Date

Latest Release
May 26, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.55
-359.11%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Financial Indicators
EPS
-4339.15%-2.26
-240.44%-0.09
-392.83%-0.14
-561.19%-0.26
-98.71%-0.05
45.04%-0.03
-202.53%-0.03
-1144.55%-0.04
-358.32%-0.03
---0.05
---0.01
--0.00
---0.01
----
Net Profit
-8612.75%-35.06M
-270.72%-1.16M
-435.68%-1.78M
-492.44%-2.66M
-35.73%-402.40K
45.03%-311.63K
-202.24%-332.52K
-1145.60%-449.36K
-358.71%-296.47K
-660.07%-566.97K
---110.02K
---36.08K
---64.63K
---74.59K
Debt to assets ratio
-98.03%6.63%
-99.90%4.62%
-99.65%5.41%
-99.13%4.74%
85.47%336.13%
7128.93%4571.07%
2066.76%1549.82%
--542.29%
--181.24%
--63.23%
--71.53%
----
----
----
Income Statement
Operating profit
-3244.34%-12.19M
-2454.32%-7.04M
-514.75%-1.84M
-522.76%-2.66M
-34.09%-364.37K
50.70%-275.61K
-188.03%-300.00K
-1437.26%-427.76K
-381.94%-271.73K
-744.70%-559.07K
---104.16K
---27.83K
---56.38K
---66.19K
Net Profit
-8612.75%-35.06M
-270.72%-1.16M
-435.68%-1.78M
-492.44%-2.66M
-35.73%-402.40K
45.03%-311.63K
-202.24%-332.52K
-1145.60%-449.36K
-358.71%-296.47K
-660.07%-566.97K
---110.02K
---36.08K
---64.63K
---74.59K
Balance Sheet
Current assets
4960.79%13.15M
106998.56%13.98M
24518.93%9.09M
13950.05%10.35M
64.79%259.90K
-96.91%13.06K
-96.00%36.91K
--73.66K
--157.72K
--422.08K
--922.73K
----
----
----
Total current liabilities
723.81%14.58M
945.21%10.71M
43.08%1.09M
65.72%809.00K
1197.23%1.77M
730.67%1.02M
101.93%761.40K
--488.17K
--136.48K
--123.31K
--377.07K
----
----
----
Total assets
54235.12%141.22M
1257338.43%164.18M
24963.09%9.25M
14217.67%10.55M
64.79%259.90K
-96.91%13.06K
-96.00%36.91K
--73.66K
--157.72K
--422.08K
--922.73K
----
----
----
Total liabilities
627.75%14.70M
690.26%10.84M
0.55%1.09M
2.71%809.00K
378.41%2.02M
251.40%1.37M
39.42%1.08M
--787.63K
--422.32K
--390.20K
--777.07K
----
----
----
Total equity
7286.26%126.52M
11391.18%153.35M
879.81%8.16M
1463.89%9.74M
-565.35%-1.76M
-4361.31%-1.36M
-818.45%-1.05M
---713.97K
---264.60K
--31.87K
--145.66K
----
----
----
Cash Flow Statement
Net operating income
-10079.33%-2.07M
-3732.92%-3.82M
-824.29%-1.73M
-1726.14%-3.36M
92.28%-20.31K
70.75%-99.62K
31.47%-186.75K
-3027.00%-184.06K
-2879.95%-263.10K
-1606.71%-340.57K
---272.50K
---5.89K
---8.83K
---19.95K
Net investment
--490.61K
---10.02M
---22.54K
---13.37K
----
----
----
----
--0.00
--0.00
----
----
--0.00
----
Net financing
244.31%920.00K
11001.54%8.49M
-100.00%0.00
11759.45%11.86M
--267.20K
--76.50K
-85.34%150.00K
--100.00K
-100.00%0.00
-100.00%0.00
--1.02M
--0.00
--9.00K
--282.90K

FAQs

What are the current assets of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its current assets were 13.98M, with a year-on-year change of 106998.56.

What are the total assets of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total assets of Apimeds Pharmaceuticals US Inc were 164.18M, with a year-on-year change of 1257338.43.

What are the total liabilities of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total liabilities of Apimeds Pharmaceuticals US Inc were 10.84M, with a year-on-year change of 690.26.

What is the total equity of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total equity of Apimeds Pharmaceuticals US Inc was 153.35M, with a year-on-year change of 11391.18.

What is the net operating income of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its net operating income of Apimeds Pharmaceuticals US Inc was -11.91M, with a year-on-year change of -834.25.

What is the net financing of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its net financing of Apimeds Pharmaceuticals US Inc was 20.62M, with a year-on-year change of 6215.26.

What is the Earnings Per Share (EPS) of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.55, with a year-on-year change of -359.11.

What is the net income of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its net income was -6.00M, with a year-on-year change of -331.74.

What is the debt-to-asset ratio of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its debt-to-asset ratio was 4.62, with a year-on-year change of -99.90.

What is the Return on Assets (ROA) of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its Return on Assets (ROA) was -7.31, with a year-on-year change of 98.86.

What is the operating profit of Apimeds Pharmaceuticals US Inc?

According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its operating profit was -11.91M, with a year-on-year change of -834.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy